Cocrystal Pharma (COCP)Director bought ~$19K

~$19K

Approx. value · 20K sh @ $0.9655

1.79M

Holds after · shares reported

Traded

Dec 30, 2025

Filed

Dec 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 14, 2025Company filing · Form 8-K · ResultsReported its results
2. Nov 25, 2025Insider · First insider buy since Apr 2023Director purchased ~$19K of COCP shares in the open market
3. Nov 26, 2025Insider · 1 personInsiders: 2 purchases (~$4K)
4. Dec 24, 2025InsiderDirector purchased ~$24K of COCP shares in the open market
5. Dec 26, 2025Insider · 14 days before an 8-KDirector purchased ~$39K of COCP shares in the open market
6. Dec 30, 2025 · this disclosureInsider · 10 days before an 8-KDirector purchased ~$19K of COCP shares in the open market

What came next

1. Dec 31, 2025Insider · 9 days before an 8-KDirector purchased ~$47K of COCP shares in the open market
2. Jan 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 9, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of Cocrystal Pharma, Inc. (the “Company”) approved the grant of non-qualified stock options to the Company’s directors, executive officers and a certain consultant.”
3. Feb 6, 2026InsiderDirector purchased ~$47K of COCP shares in the open market
4. Feb 24, 2026Insider · 14 days before an 8-KDirector purchased ~$20K of COCP shares in the open market
5. Mar 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Cocrystal Pharma, Inc. (the “Company”) sadly learned on March 10, 2026 that Dr. Anthony Japour, a member of the Company’s board of directors, passed away.”
6. Mar 31, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cocrystal Pharma

For Cocrystal Pharma, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COCP page.

Other recent filings by FROST PHILLIP MD ET AL, Director

• SEC Form 4 at Cocrystal Pharma (COCP)Aug 6, 2026
• SEC Form 4 at Cocrystal Pharma (COCP)Aug 5, 2026
• SEC Form 4 at Cocrystal Pharma (COCP)Feb 25, 2026
• SEC Form 4 at Cocrystal Pharma (COCP)Feb 9, 2026
• SEC Form 4 at Cocrystal Pharma (COCP)Jan 2, 2026

The full history of FROST PHILLIP MD ET AL, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cocrystal Pharma

• SEC Form 4Aug 6, 2026
• SEC Form 4Aug 5, 2026
• SEC Form 4Feb 25, 2026
• SEC Form 4Feb 9, 2026
• SEC Form 4Jan 2, 2026
• SEC Form 4Dec 29, 2025

Everything OQRO holds on this company is on its COCP page.